Evidence map›Paper›PMID 31341171›Full record

ArticleNature communications2019

Highly branched  poly(β-amino ester) delivery of minicircle DNA for transfection of neurodegenerative disease related cells.

Shuai Liu, Yongsheng Gao, Dezhong Zhou, Ming Zeng, Fatma Alshehri, Ben Newland, Jing Lyu, Jonathan O'Keeffe-Ahern, Udo Greiser, Tianying Guo and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 139 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Tissue-specific gene delivery approaches.Bioengineering & translational medicine · 2026
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Highly branched poly β-amino ester/CpG-depletedMolecular therapy. Methods & clinical development · 2024
    Article
  20. Nonviral CRISPR/Cas9 mutagenesis for streamlined generation of mouse lung cancer models.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Shuai LiuCharles Institute of Dermatology, School of Medicine, University College Dublin, Belfield, 4, Dublin, Ireland.ORCID http://orcid.org/0000-0002-8405-6743
Yongsheng GaoCharles Institute of Dermatology, School of Medicine, University College Dublin, Belfield, 4, Dublin, Ireland.
Dezhong ZhouCharles Institute of Dermatology, School of Medicine, University College Dublin, Belfield, 4, Dublin, Ireland. dezhong.zhou@ucd.ie.
Ming ZengCharles Institute of Dermatology, School of Medicine, University College Dublin, Belfield, 4, Dublin, Ireland.
Fatma AlshehriCharles Institute of Dermatology, School of Medicine, University College Dublin, Belfield, 4, Dublin, Ireland.
Ben NewlandSchool of Pharmacy and Pharmaceutical Sciences, Cardiff University, CF103AT, Cardiff, UK.
Jing LyuCharles Institute of Dermatology, School of Medicine, University College Dublin, Belfield, 4, Dublin, Ireland.
Jonathan O'Keeffe-AhernCharles Institute of Dermatology, School of Medicine, University College Dublin, Belfield, 4, Dublin, Ireland.
Udo GreiserCharles Institute of Dermatology, School of Medicine, University College Dublin, Belfield, 4, Dublin, Ireland.
Tianying GuoKey Laboratory of Functional Polymer Materials, Ministry of Education, Institute of Polymer Chemistry, College of Chemistry, Nankai University, 300071, Tianjin, China. tyguo@nankai.edu.cn.ORCID http://orcid.org/0000-0001-6587-6466
Fengzhi ZhangSchool of Pharmaceutical Science, Zhejiang University of Technology, 310014, Hangzhou, China.
Wenxin WangCharles Institute of Dermatology, School of Medicine, University College Dublin, Belfield, 4, Dublin, Ireland. wenxin.wang@ucd.ie.ORCID http://orcid.org/0000-0002-5053-0611
University College Dublin · IECardiff University · GBNankai University · CNZhejiang University of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current therapies for most neurodegenerative disorders are only symptomatic in nature and do not change the course of the disease. Gene therapy plays an important role in disease modifying therapeutic strategies. Herein, we have designed and optimized a series of highly branched poly(β-amino ester)s (HPAEs) containing biodegradable disulfide units in the HPAE backbone (HPAESS) and guanidine moieties (HPAESG) at the extremities. The optimized polymers are used to deliver minicircle DNA to multipotent adipose derived stem cells (ADSCs) and astrocytes, and high transfection efficiency is achieved (77% in human ADSCs and 52% in primary astrocytes) whilst preserving over 90% cell viability. Furthermore, the top-performing candidate mediates high levels of nerve growth factor (NGF) secretion from astrocytes, causing neurite outgrowth from a model neuron cell line. This synergistic gene delivery system provides a viable method for highly efficient non-viral transfection of ADSCs and astrocytes.

Indexed as

AstrocytesGenetic TherapyHumansMesenchymal Stem CellsNerve Growth FactorNeurodegenerative DiseasesPolymersTransfectionNerve Growth Factorpoly(beta-amino ester)Polymers

Identifiers

PMID31341171
PMCPMC6656726
OpenAlexW2963848341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.